Quantification of intact human insulin‐like growth factor‐I in serum by nano‐ultrahigh‐performance liquid chromatography/tandem mass spectrometry. (22nd May 2014)

• Record Type: Journal Article
• Authors: Lopes, Filipe; Cowan, David A.; Thevis, Mario; Thomas, Andreas; Parkin, Mark C.
• Is Part Of: Rapid communications in mass spectrometry. Volume 28:Number 13(2014)
• Page Start: 1426
• Page End: 1432
• Publication Date: 2014-05-22
• Subjects: Mass spectrometry -- Periodicals; 543.65
• DOI: 10.1002/rcm.6908
• Languages: English
• ISSNs: 0951-4198

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="rcm6908-sec-0001" sec-type="section"> <title>RATIONALE</title> <p>Insulin‐like growth factor‐I is one of the biomarkers used to detect growth hormone administration prohibited in human sport. Current testing approaches for IGF‐I rely on commercial immunoassays, which may change from time to time requiring complex revalidation. Mass spectrometry (MS)‐based approaches often rely on enzymatically digesting the protein and measuring specific peptide concentrations. In order to reinforce the current available methodology for IGF‐I testing, a reliable and equally sensitive MS method is required for the analysis of intact protein using small sample volumes (<25 μL).</p> </sec> <sec id="rcm6908-sec-0002" sec-type="section"> <title>METHODS</title> <p>IGF‐I was extracted from human serum samples by a simple protein precipitation procedure. Separation was achieved via nano‐ultrahigh‐performance liquid chromatography and MS analysis was conducted by nano‐electrospray ionisation triple‐quadrupole mass spectrometry in the selected reaction monitoring mode using a stable‐isotope‐labelled internal standard.</p> </sec> <sec id="rcm6908-sec-0003" sec-type="section"> <title>RESULTS</title> <p>A six‐point calibration curve ranging from 50 to 1000 ng/mL of human IGF‐I in rat serum was used to establish instrument response. The method provided a limit of quantification of 50 ng/mL, with intra‐ and inter‐day precision ≤5% and intra‐ and inter‐day accuracy ≥95%.</p> </sec> <sec id="rcm6908-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>A quantitative method was developed for the quantification of intact IGF‐I in human serum samples. The data generated provided important information for the development of a new reference method for the growth hormone biomarker test and helped create a reliable system for monitoring peptide hormones in individual athletes, a possible extension to the athlete biological passport system. Nano‐electrospray has here been shown to be sufficiently robust for routine use in an analytical laboratory, allowing for the analysis of minute sample volumes. Copyright © 2014 John Wiley & Sons, Ltd.</p> </sec> </abstract>